Quality of Life the Danish Multiple Myeloma Patients

A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

NCT06577025 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Bone Pain in Multiple Myeloma- a Translational Study

NCT04273425 ·Status: UNKNOWN

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies

NCT02997813 ·Status: COMPLETED

Denosumab for Smoldering Multiple Myeloma

NCT03839459 ·Status: COMPLETED ·Phase: PHASE2

A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)

NCT05001087 ·Status: RECRUITING

Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)

NCT05276622 ·Status: TERMINATED

Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers

NCT07014865 ·Status: RECRUITING

Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone

NCT03375567 ·Status: COMPLETED ·Phase: NA

A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain

NCT02946333 ·Status: COMPLETED

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

NCT06212323 ·Status: RECRUITING

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

NCT04533217 ·Status: RECRUITING ·Phase: NA

Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression

NCT04872023 ·Status: COMPLETED ·Phase: NA

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

NCT00907452 ·Status: COMPLETED ·Phase: NA

Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

NCT04888039 ·Status: RECRUITING

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

NCT02252172 ·Status: COMPLETED ·Phase: PHASE3

The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study

NCT06610045 ·Status: COMPLETED

PRospective Multiple Myeloma Impact Study

NCT02911571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

NCT04497961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)

NCT04135963 ·Status: COMPLETED

CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma

NCT03150316 ·Status: UNKNOWN ·Phase: PHASE1

MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis?

NCT03618212 ·Status: TERMINATED

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

NCT02378701 ·Status: COMPLETED

Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma

NCT03490084 ·Status: UNKNOWN

Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma

NCT01272466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

NCT04923893 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3